Beijing Percutaneous Coronary Intervention Registry

NCT ID: NCT01417325

Last Updated: 2018-01-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

700000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-01-31

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients from selected 48 hospitals of Beijing, P.R.China
* Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion Criteria

* none
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yuejin Yang

Director of coronary heart disease center, vice president of Fuwai hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yuejin Yang, doctor

Role: STUDY_CHAIR

Fuwai Heart Hospital & Cardiovascular Institute

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing cardiovascular intervention quality control and improvement center

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuejin Yang, Doctor

Role: CONTACT

8610-68314466

Lei Song, Doctor

Role: CONTACT

8610-13910968125

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yuejin Yang, doctor

Role: primary

8610-88398800

Lei Song, doctor

Role: backup

8610-13910968125

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Bciqcic-fw-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rota China Registry
NCT03806621 COMPLETED
Perfusion CT Registry
NCT01696006 COMPLETED